15-19 May 2026 Stockholm, Sweden
Table of contents
Abstract Reviewers Acknowledgement...............................................................................................................................1-3
BRACHYTHERAPY
Breast.................................................................................................................................................................................... 4-16 Gastro-intestinal, paediatric brachytherapy, miscellaneous.........................................................................................17-30 General brachytherapy.....................................................................................................................................................31-44 Gynaecology........................................................................................................................................................................4 -91 Head & neck, skin, eye....................................................................................................................................................92-110 Physics............................................................................................................................................................................ 111-149 Urology........................................................................................................................................................................... 150-179
CLINICAL
Biomarkers of clinical response...................................................................................................................................180-199 Breast.............................................................................................................................................................................. 200-352 CNS.................................................................................................................................................................................. 353-397 Gynaecological............................................................................................................................................................... 398-497 Haematology.................................................................................................................................................................. 498-527 Head & neck...................................................................................................................................................................528-676 Lower GI.........................................................................................................................................................................677-746 Lung................................................................................................................................................................................ 747-855 Mixed sites/palliation....................................................................................................................................................856-937 Non-malignant and functional radiotherapy..............................................................................................................938-961 Oligometastatic cancer.................................................................................................................................................962-997 Paediatric tumours......................................................................................................................................................998-1028 Sarcoma, skin cancer, malignant melanoma............................................................................................................102-1060 Upper GI.....................................................................................................................................................................1061-1126 Urology.......................................................................................................................................................................1127-1320
INTERDISCIPLNARY
Education in radiation oncology..............................................................................................................................1321-1350 Global health..............................................................................................................................................................1351-1376 Health economics & health services research........................................................................................................1377-1431 Other...........................................................................................................................................................................1432-1470 Patient involvement..................................................................................................................................................1471-1491 Public engagement and visibility of radiotherapy..................................................................................................1492-1498 Quality assurance and risk management...............................................................................................................1499-1542
Made with FlippingBook - Share PDF online